We are live on ! Find out more
ADEF

ABS Direct Equity Fund Portfolio holdings

AUM $131M
1-Year Est. Return 7.53%
This Fund
S&P 500
This Quarter Est. Return
-2.14%
1 Year Est. Return
+7.53%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$131M
AUM Growth
+$46.8M
Cap. Flow
+$52.6M
Cap. Flow %
40.23%
Top 10 Hldgs %
44.1%
Holding
117
New
81
Increased
15
Reduced
9
Closed
8

Top Buys

Rank Stock Value
1
STNE icon
StoneCo
STNE
+$7.38M
2
INTR icon
Inter&Co
INTR
+$5.05M
3
MELI icon
Mercado Libre
MELI
+$4.63M
4
NU icon
Nu Holdings
NU
+$4.01M
5
PAM icon
Pampa Energía
PAM
+$3.97M

Top Sells

Rank Stock Value
1
AMX icon
America Movil
AMX
+$5.38M
2
POWL icon
Powell Industries
POWL
+$3.68M
3
YMM icon
Full Truck Alliance
YMM
+$2.93M
4
PHIN icon
Phinia Inc
PHIN
+$1.75M
5
BMA icon
Banco Macro
BMA
+$1.47M

Sector Composition

Rank Sector Weight
1 Technology 26.57%
2 Consumer Discretionary 17.3%
3 Industrials 15.96%
4 Financials 9.21%
5 Materials 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GH icon
76
Guardant Health
GH
$21.5B
$210K 0.16%
+2,300
New +$231K
ICLR icon
77
Icon
ICLR
$12.6B
$202K 0.15%
+1,800
New +$246K
CRWV
78
CoreWeave
CRWV
$39.2B
$201K 0.15%
+1,600
New +$139K
VRT icon
79
Vertiv
VRT
$93B
$199K 0.15%
+600
New +$133K
CRDO icon
80
Credo Technology Group
CRDO
$38.6B
$198K 0.15%
+1,100
New +$134K
LLY icon
81
Eli Lilly
LLY
$1.02T
$194K 0.15%
+200
New +$203K
SYRE icon
82
Spyre Therapeutics
SYRE
$8.54B
$194K 0.15%
+2,800
New +$106K
JAZZ icon
83
Jazz Pharmaceuticals
JAZZ
$15.9B
$187K 0.14%
+900
New +$157K
RPRX icon
84
Royalty Pharma
RPRX
$25.9B
$181K 0.14%
+3,600
New +$158K
DNTH icon
85
Dianthus Therapeutics
DNTH
$5.84B
$179K 0.14%
+2,000
New +$116K
CGON icon
86
CG Oncology
CGON
$6.28B
$176K 0.13%
+2,600
New +$147K
EW icon
87
Edwards Lifesciences
EW
$49.6B
$175K 0.13%
+2,100
New +$173K
COGT icon
88
Cogent Biosciences
COGT
$6.65B
$173K 0.13%
+4,700
New +$174K
CRL icon
89
Charles River Laboratories
CRL
$11.2B
$172K 0.13%
+1,000
New +$185K
U icon
90
Unity
U
$13.8B
$169K 0.13%
+6,100
New +$169K
ALKS icon
91
Alkermes
ALKS
$8.22B
$167K 0.13%
+4,900
New +$152K
ISRG icon
92
Intuitive Surgical
ISRG
$127B
$163K 0.12%
+360
New +$182K
RNTX
93
Rein Therapeutics
RNTX
$63.1M
$163K 0.12%
125,000
SPOT icon
94
Spotify
SPOT
$103B
$158K 0.12%
+360
New +$181K
SYK icon
95
Stryker
SYK
$125B
$151K 0.12%
+520
New +$187K
DXCM icon
96
DexCom
DXCM
$32.2B
$150K 0.11%
+2,500
New +$174K
GEHC icon
97
GE HealthCare
GEHC
$30.7B
$146K 0.11%
+2,400
New +$189K
ACTU
98
Actuate Therapeutics
ACTU
$26.6M
$137K 0.1%
50,000
+43,403
+658% +$180K
PRAX icon
99
Praxis Precision Medicines
PRAX
$8.58B
$135K 0.1%
+400
New +$124K
TER icon
100
Teradyne
TER
$57.6B
$135K 0.1%
+400
New +$112K

Similar funds

ABS Direct Equity Fund's Q1 2026 Portfolio in Review

As of Q1 2026, ABS Direct Equity Fund held 117 positions worth $131M, up 56% from $84.1M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

ABS Direct Equity Fund deployed $52.6M of net new capital in Q1 2026, opening 81 new positions and adding to 15 existing holdings. Its largest new stake was StoneCo: 480,350 shares worth $5.76M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was America Movil, an estimated $5.38M trimmed.

  • ABS Direct Equity Fund's largest Q1 2026 buy was StoneCo: 480,350 shares worth $5.76M.
  • ABS Direct Equity Fund added most to Mercado Libre in Q1 2026, an estimated $4.63M increase.
  • ABS Direct Equity Fund's biggest Q1 2026 reduction was America Movil, cutting an estimated $5.38M.
  • ABS Direct Equity Fund fully exited Full Truck Alliance in Q1 2026, selling an estimated $2.93M.
  • ABS Direct Equity Fund's ten largest holdings make up 44% of its $131M portfolio in Q1 2026.
  • ABS Direct Equity Fund opened 81 new positions and closed 8 in Q1 2026.
  • ABS Direct Equity Fund's portfolio value rose 56% quarter-over-quarter to $131M.

Based on ABS Direct Equity Fund's 13F filing for Q1 2026, filed 15 May 2026.